Barsian Darou participation in Heart Failure 2018

Barsian Darou participation in Heart Failure 2018


Event date: Saturday 26 – Tuesday 29 May 2018

Location: Vienna – Austria


Barsian Darou was honored to be part of the sponsorship for Iranian Cardiologists (with Heart failure subspecialty) participation in Heart Failure 2018 congress. 


Event Summary:

HFA is the world’s leading congress for experts in cardiology to discuss strategies for a universal approach towards prevention and the treatment of heart failure. Heart Failure and the World Congress on Acute Heart Failure are annual congresses of the Heart Failure Association (HFA) of the ESC. Heart Failure 2018 was under the theme ‘Heart failure: Classical repertoire, modern instruments’, aims to discuss how the latest techniques can be best combined to optimize medical and device management so that experts can ultimately improve symptoms and outcomes in the patients with heart failure.

The world’s premier heart failure conference, the HFA congress was invaluable in providing delegates with a forum in which to access and discuss cutting-edge information on heart failure with peers and experts and to learn how to integrate all the different aspects to ensure the best possible outcomes. The time has come to step back and consider heart failure in the context of cardiac disease as a whole, to look at the bigger picture. HFA has transformed itself to broaden the understanding of heart failure and its treatment and this is why Heart Failure 2018 looks different to previous congresses. The days had passed when drugs were the mainstay of heart failure treatment and specialists now also use a range of devices and interventions to improve patient outcome. The art lies in working out the optimal integration of different treatment modalities for individual patients.

This year`s program, included a faculty encompassing all the different cardiovascular medicine subspecialties, including electrophysiologists, interventionists and surgeons, as well as primary care physicians, nurses, social workers and psychologists, among many others.


Heart Failure 2018 brilliantly put multidisciplinary care on the map of heart failure management.


Barsian Darou Participation in Heart Failure 2018 Industry Sponsored Symposia

Companies were invited to organize Satellite Symposia included in the Heart Failure scientific program. These sessions offered pertinent data on the latest scientific information and developments from the industry. Satellite Symposia were held within the congress center in lecture rooms.


Saturday, 26 May 2018, 12:15-13:15, Room Budapest

Topic: “Iron deficiency: an important comorbidity” 

Chair: Peter van der Meer (The Netherlands), Stefan Anker(Germany)

Organised by: Vifor Pharma


12:15-12:30   Why is iron deficiency recognized as an important comorbidity in heath failure? (Speaker: Peter van der Meer)

12:30-12:40  Identifying iron deficiency in practice: understanding the correct diagnosis of iron deficiency in heart failure patients (Speaker: Ewa Jnkowska)

12:40-12:50   The ESC 2016 heart failure guidelines: what is the recommendation for iron deficiency and why? (Speaker: Stefan Anker)

12:50-13:00   Managing iron deficiency: a practical approach (Speaker: Carolyn Lam)

13:00-13:15   Iron deficiency: an important comorbidity- Q & A and conclusion (Speaker: Stefan Anker)


Barsian Darou participation in the Exhibition Center’s programs

Vifor Pharma was one of the pharmaceutical companies actively present in its congress exhibition center’s program and all the scientific questions regarding to Vifor Pharma’s products were fully addressed in the booth.

Vifor Pharma, is a global pharmaceutical company that researches, develops, produces and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies and strives to help patients around the world with severe and chronic diseases to lead better, healthier lives.

Vifor Pharma Group has production sites in Switzerland and Portugal as well as a dynamic network of affiliates and partners offering broad market coverage all over the world. Barsian Darou is in collaboration and partnership with Vifor Pharma.


About the Heart Failure Association of the ESC

With a mission ‘To improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research’ HFA is a worldwide reference for education in the field of heart failure and also disseminate this knowledge to a younger audience. Over the last decade it has undergone an extraordinary growth and developed into a vibrant organization that has done much to raise the profile of heart failure in Europe. It is the largest association of heart failure healthcare professionals with more than 10 000 members worldwide. There is an exceptional international network across all continents and numerous activities with the support and close collaboration of more than 50 National Heart Failure Societies and Working Groups.


(For more info on HFA 2018 go to the reference: